Swanson J, Posner M, Fusella J, Wasdell M, Sommer T, Fan J
Child Development Center, University of California at Irvine, 19722 MacArthur Boulevard, Irvine, CA 92612, USA. jmswanso@uci,edu
Curr Psychiatry Rep. 2001 Apr;3(2):92-100. doi: 10.1007/s11920-001-0005-2.
The initial molecular genetic studies of attention deficit hyperactivity disorder (ADHD) evaluated two candidate genes (DAT and DRD4) suggested by dopamine theories of this common disorder and its treatment with stimulant medication. The initial reports of weak associations with ADHD have been replicated by many (but not all) investigators, as is expected for genes with small effects. This literature is reviewed, along with emerging literature generated by active research groups investigating additional genes that might contribute to the genetic basis of this complex disorder.
对注意力缺陷多动障碍(ADHD)的初步分子遗传学研究评估了多巴胺理论针对这种常见疾病及其使用兴奋剂药物治疗所提出的两个候选基因(DAT和DRD4)。许多(但并非所有)研究者都重复了与ADHD存在微弱关联的初步报告,这对于效应较小的基因来说是意料之中的。本文对这一文献进行了综述,同时也回顾了活跃研究小组所产生的新文献,这些小组正在研究可能促成这种复杂疾病遗传基础的其他基因。